Barry E. Gidal

4.9k total citations
68 papers, 2.4k citations indexed

About

Barry E. Gidal is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Barry E. Gidal has authored 68 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pediatrics, Perinatology and Child Health, 47 papers in Psychiatry and Mental health and 14 papers in Oncology. Recurrent topics in Barry E. Gidal's work include Pharmacological Effects and Toxicity Studies (53 papers), Epilepsy research and treatment (47 papers) and Pharmaceutical studies and practices (14 papers). Barry E. Gidal is often cited by papers focused on Pharmacological Effects and Toxicity Studies (53 papers), Epilepsy research and treatment (47 papers) and Pharmaceutical studies and practices (14 papers). Barry E. Gidal collaborates with scholars based in United States, United Kingdom and Belgium. Barry E. Gidal's co-authors include Richard H. Mattson, Gary L. Lensmeyer, Emilio Perucca, Scott Mintzer, Charles J. Vecht, Dieter Schmidt, Alison Pack, Martin J. Brodie, Jim Ferry and Raj D. Sheth and has published in prestigious journals such as Neurology, The Lancet Neurology and Epilepsia.

In The Last Decade

Barry E. Gidal

66 papers receiving 2.3k citations

Peers

Countries citing papers authored by Barry E. Gidal

Since Specialization

Citations

This map shows the geographic impact of Barry E. Gidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry E. Gidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry E. Gidal more than expected).

Fields of papers citing papers by Barry E. Gidal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry E. Gidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry E. Gidal. The network helps show where Barry E. Gidal may publish in the future.

Co-authorship network of co-authors of Barry E. Gidal

This figure shows the co-authorship network connecting the top 25 collaborators of Barry E. Gidal. A scholar is included among the top collaborators of Barry E. Gidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry E. Gidal. Barry E. Gidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Coffee and cigarette smoking interactions with lamotrigine 2021 ·Epilepsy & Behavior ·Timothy E. Welty, Barry E. Gidal, (unknown), Michael Privitera, Michel J. Berg, Ron Krebill, Jerzy P. Szaflarski, Francisco J. Díaz	4
2	Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for clinicians 2021 ·Epilepsy & Behavior ·Barry E. Gidal, Jim Ferry, Larisa Reyderman, J. Eric Piña-Garza	16
3	Effects of enzyme-inducing antiseizure medication on vitamin D dosing in adult veterans with epilepsy 2020 ·Epilepsy Research ·(unknown), (unknown), Amanda Margolis, (unknown), Barry E. Gidal	11
4	A review of the drug−drug interactions of the antiepileptic drug brivaracetam 2020 ·Epilepsy Research ·Brian D. Moseley, Hugues Chanteux, Jean‐Marie Nicolas, (unknown), Barry E. Gidal, Armel Stockis	39
5	Vitamin D abnormalities and bone turn over analysis in children with epilepsy in the Western Cape of South Africa. 2019 ·Seizure ·Edward Kija, Barry E. Gidal, Alexander Shapson-Coe, (unknown), (unknown), (unknown), Jo M. Wilmshurst	9
6	Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy 2019 ·Epilepsy Research ·Scott Mintzer, (unknown), Barry E. Gidal, Parul Bhargava, Todd Grinnell, David Blum	5
7	Time course of reversal of valproate-mediated inhibition of lamotrigine 2018 ·Seizure ·(unknown), Raj D. Sheth, Barry E. Gidal	3
8	Continuity of Care With IV Carbamazepine: A Case Report for Maintaining Treatment (P5.235) 2017 ·Neurology ·Martin J. Brodie, Pavel Klein, Raman Sankar, Barry E. Gidal, Dwain Tolbert	0
9	Abuse Potential of Antiepileptic Drugs: a Review Using the VigiBase ^TM Pharmacovigilance Database (P1.233) 2015 ·Neurology ·Barry E. Gidal, David Blum	2
10	Enzyme induction with antiepileptic drugs: Cause for concern? 2012 ·Epilepsia ·Martin J. Brodie, Scott Mintzer, Alison Pack, Barry E. Gidal, Charles J. Vecht, Dieter Schmidt	284
11	Conversions between monotherapies in epilepsy: Expert consensus 2007 ·Epilepsy & Behavior ·Erik K. St. Louis, Barry E. Gidal, Thomas R. Henry, (unknown), Allan Krumholz, (unknown), Georgia Montouris, William E. Rosenfeld, Brien Smith, John M. Stern, Elizabeth Waterhouse, Richard Schulz, William R. Garnett, Thomas Bramley	29
12	Oral absorption kinetics of levetiracetam: The effect of mixing with food or enteral nutrition formulas 2005 ·Clinical Therapeutics ·(unknown), Raj D. Sheth, Barry E. Gidal	29
13	Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials 2003 ·Epilepsy Research ·Barry E. Gidal, Raj D. Sheth, Leslie Magnus, (unknown)	36
14	Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials 2003 ·Epilepsy Research ·Emilio Perucca, Barry E. Gidal, Eugène Baltes	88
15	Evaluation of a Rat Model of Valproate‐Induced Obesity 1998 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Tami Wolden‐Hanson, Barry E. Gidal, Richard L. Atkinson	15
16	Lamotrigine pharmacokinetics in patients receiving felbamate 1997 ·Epilepsy Research ·Barry E. Gidal, Andrés M. Kanner, (unknown), Paul Rutecki, Gary L. Lensmeyer	13
17	Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy 1997 ·Epilepsy Research ·Barry E. Gidal, Paul Rutecki, (unknown), (unknown), David Collins, Michael E. Pitterle	21
18	Effect of a high-protein meal on gabapentin pharmacokinetics 1996 ·Epilepsy Research ·Barry E. Gidal, (unknown), (unknown), Gary L. Lensmeyer, Michael E. Pitterle, J.C. Jones	31
19	Potential Pharmacokinetic Interaction between Felbamate and Phenobarbital 1994 ·Annals of Pharmacotherapy ·Barry E. Gidal, Mary L. Zupanc	19
20	Potential Interaction between Carbamazepine and Loxapine: Case Report and Retrospective Review 1993 ·Annals of Pharmacotherapy ·(unknown), Barry E. Gidal, Michael E. Pitterle	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact